Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PSIAARP: Smoking Cessation in Schizophrenia
NCT00495352Phase 4Completed
- Sponsor
- Yu-Li Hospital
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nicotine, bupropion in tobacco dependence, sponsored by Yu-Li Hospital. Started Jan 2006; status: completed.
02
Drugs
nicotinebupropion
03
Conditions
tobacco dependence
Beyond the preview
Go deeper on NCT00495352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00495352.